(Q34293607)

1 August 2017

1 reference

title

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer (English)

1 reference

1 August 2017

1 reference

1 reference

Kirn D

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

56

1 reference

1 August 2017

page(s)

6660-6669

1 reference

Immunomodulation of cancer: potential use of selectively replicating agents

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Treatment of human cancer with mumps virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Adenovirus 2 Ip+ locus codes for a 19 kd tumor antigen that plays an essential role in cell transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Replication-selective adenoviruses as oncolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Replication-selective microbiological agents: fighting cancer with targeted germ warfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

A tale of two trials: selectively replicating herpesviruses for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Conditionally replicating herpes vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Poxvirus vectors: orphaned and underappreciated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Reovirus as a novel oncolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Studies on the use of viruses in the treatment of carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Use of preferentially replicating bacteria for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Cellular targets for transformation by the adenovirus E1A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Adenovirus proteins that subvert host defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

ONYX-015: clinical data are encouraging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204094

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204094

1 reference

Dimensions Publication ID

1 August 2017

1027120309

0 references

1 reference